Talkot Capital’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Talkot Capital’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-75,291	Closed	-$62K	–	36
2015 Q3	$62K	Hold	75,291	–	–	0.05%	19
2015 Q2	$103K	Sell	75,291 -1	-0%	-$2	0.08%	17
2015 Q1	$192K	Buy	75,292 +33,334	+79%	+$131K	0.13%	27
2014 Q4	$191K	Hold	41,958	–	–	0.14%	17
2014 Q3	$369K	Buy	41,958 +25,000	+147%	+$247K	0.26%	15
2014 Q2	$250K	Buy	+16,958	New	+$294K	0.17%	18

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Talkot Capital's RCPI Position: Q4 2015 in Review

Talkot Capital sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 75,291 shares — an estimated $62K sold.

Talkot Capital first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $369K in Q3 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

Talkot Capital reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Talkot Capital sold 75,291 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $62K.
Talkot Capital first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
Talkot Capital's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $369K in Q3 2014.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Talkot Capital's 13F filing for Q4 2015, filed 12 Feb 2016.